InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,395.89
(
0.96%
)
US TECH 100
18,270.40
(
1.19%
)
Dow Jones
39,609.39
(
0.64%
)
Brent Oil
80.91
(
-0.86%
)
Bitcoin
59,402.16
(
0.07%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: mysscat post# 11654

Monday, 02/04/2008 9:02:07 PM

Monday, February 04, 2008 9:02:07 PM

Post# of 30387
Mysscat, You might want to read up on some of the press releases in the past year or so. BioCurex has developed the technology to freeze dry the reagents. Read that carefully. The histo RECAF reagents can now be safely shipped and why on earth would Inverness want to sell a kit to collect tissue samples to test for cervical cancer and not use the best staining capability out there.

We shall see but I bet I am correct.

Dr. Moro has stated that this deal will produce revenue very soon. Inverness's collection system to prepare tissue samples for cervical cancer testing would be a class I device and would not require FDA approval or at a maximum, a 510(K). Histo RECAF is a class I device and does not required FDA approval. Does this begin to make sense to you now?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up